Peripheral Artery Disease
The most common cause of peripheral artery disease (PAD) is atherosclerosis. Less common etiologies include inflammatory disorders of the arterial wall (vasculitis) and noninflammatory arteriopathies, such as fibromuscular dysplasia.
Two broad subtypes of PAD are associated with different risk factor and comorbidity profiles: proximal, involving the aortoiliac and femoro-popliteal locations, and distal, involving the infra-popliteal location. Distal disease may be accompanied by medial arterial calcification that leads to poorly compressible arteries and is associated with higher mortality rates.
Based on the prevalence in cohort studies of an abnormal ankle-brachial index (ABI) — the ratio of systolic blood pressure (BP) at the ankle to the systolic BP in the arm — it's estimated that at least 5 million people in the United States and more than 200 million people worldwide have peripheral artery disease (also called peripheral arterial disease). The total annual costs associated with hospitalization of patients with PAD in the U.S. are estimated to be in excess of $21 billion, a number projected to rise as the population ages.
Research in the Atherosclerosis and Lipid Genomics Lab on PAD includes epidemiology, genetic epidemiology, biomarkers and outcomes.
Adelaide M. Arruda-Olson, M.D., Ph.D., is studying the use of informatics approaches to ascertain PAD from the electronic health record and to conduct population-based epidemiologic studies. In addition, Dr. Arruda-Olson is developing an automated estimation of prognostic scores for PAD with linkage to clinical decision support. Read more about Dr. Arruda-Olson's research.
- Kullo IJ, Rooke TW. Peripheral artery disease. New Engl J Med. 2016;374:861-71. [PMID 26962905].
- Leeper NJ, Kullo IJ, Cooke JP. Genetics of peripheral artery disease. Circulation. 2012;125(25):3220-8. [PMID: 22733336; PMC3755373].
- Fan J, Arruda-Olson AM, Leibson CL, Smith C, Liu G, Bailey KR, Kullo IJ. Billing code algorithms to identify cases of peripheral artery disease from administrative data. J Am Med Inform Assoc. 2013;20(e2):e349-54. [PMID: 24166724; PMC3861931].
- Masud R, Shameer K, Dhar A, Ding K, Kullo IJ. Gene expression profiling of peripheral blood mononuclear cells in the setting of peripheral arterial disease. J Clin Bioinforma. 2012;2:6. [PMID: 22409835; PMC3381689].
- Barretto SN, Ballman KV, Rooke TW, Kullo IJ. Early-onset peripheral arterial occlusive disease: clinical features and determinants of disease severity and location. Vasc Med. 2003;8:95-100. [PMID: 14518611].
- Ye Z, Smith C, Kullo IJ. Usefulness of red cell distribution width to predict mortality in patients with peripheral artery disease. Am J Cardiol. 2011 Apr 15;107(8):1241-5. [PMID: 21296321; PMC3209662].
- Arain FA, Ye Z, Bailey KR, Chen Q, Liu G, Leibson CL, Kullo IJ. Survival in patients with poorly compressible leg arteries. J Am Coll Cardiol. 2012 Jan 24;59(4):400-7. [PMID: 22261162; PMC3307094].
- Ye Z, Ali Z, Klee GG, Mosley Th Jr, Kullo IJ. Associations of candidate biomarkers of vascular disease with the ankle-brachial index and peripheral arterial disease. Am J Hypertension. 2013 Apr;26(4):495-502. [PMID: 23467205; PMC3626040].
- Chen Q, Smith CY, Bailey KR, Wennberg PW, Kullo IJ. Disease location is associated with survival in patients with peripheral arterial disease. J Am Heart Assoc. 2013;2(5):e000304. [PMID: 24145740; PMC3835235].
- Singh S, Bailey KR, Kullo IJ. Ethnic differences in ankle brachial index are present in middle-aged individuals without peripheral arterial disease. Int J Cardiol. 2013;162(3):228-33. [PMID: 21652099; PMC3174274].
- Fan J, Jouni H, Khaleghi M, Bailey KR, Kullo IJ. Serum N-terminal pro-B-type natriuretic peptide levels are associated with functional capacity in patients with peripheral arterial disease. Angiology. 2012;63(6):435-442. [PMID: 22096207; PMC3855435].